BRAMPTON, Ont. — Loblaw beat analyst forecasts for the quarter, the Financial Post reports, boosted by strong sales in its pharmacy business at Shoppers Drug Mart, which the retail group acquired this year. Same-store front sales grew 2.5% at Shoppers, while Loblaw saw overall 1.6% growth. Loblaw’s revenue rose 36% to $13.6 billion, a quarter of that coming from Shoppers Drug Mart. The merger saved Loblaw about $44 million in the quarter, but also cost it $46 million in restructuring and reorganization expenses. Net earnings fell to $142 million from $150 million. Adjusted basic net earnings was 90 cents per share, slightly ahead of the average forecast of 87 cents.
Shoppers deal buoys Loblaw results
Most Recent
Most Read
Weyerhaeuser sales, earnings slip in Q2
Fri, July 26th, 2024
Don’t miss the incredible speakers at the Hardlines Conference!
Fri, July 26th, 2024
Canfor announces CEO succession
Thu, July 25th, 2024
West Fraser reverses Q2 loss
Thu, July 25th, 2024
Tractor Supply’s comp sales dip in Q2
Thu, July 25th, 2024
Loblaw turns in mixed Q2 results, strong online sales
Thu, July 25th, 2024
In memoriam: blues rock legend John Mayall
Thu, July 25th, 2024
Barcodes turn 50
Wed, July 24th, 2024
Featured Classified: RONA
Wed, July 24th, 2024
RONA affiliate makes acquisitions in Ottawa area
Tue, July 23rd, 2024